Vivli is delighted to announce the publication of a new collection in Wellcome Open Research showcasing the finalists and winners of the 2023 Vivli AMR Surveillance Open Data Re-Use Data Challenge, funded by Wellcome. This growing collection includes nine articles from participating research teams, as well as an editorial co-authored by members of the judges’ panel and Vivli team.
This collection is envisioned as a living resource, and finalists and winners from the 2024 Vivli AMR Surveillance Data Challenge, funded by GARDP, Paratek, Pfizer, and Vivli, that is currently underway, will also be invited to submit an article. The included articles highlight the range of diverse, impactful, and innovative solutions developed by the teams participating in the Data Challenge, leveraging data from the Vivli Antimicrobial Resistance (AMR) Register to contribute to resolving the AMR crisis. The first two articles to complete peer review approval are now available on the Wellcome Open Research website:
From our Grand Prize winning team –
“Investigating the feasibility and potential of combining industry AMR monitoring systems: a comparison with WHO GLASS” by Fredrick Mutisya and Rachael Kanguha
From an Impact Award winning team –
“MIC distribution analysis identifies differences in AMR between population sub-groups” by Eve Rahbé, Aleksandra Kovacevic, Lulla Opatowski, and Quentin J. Leclerc
The escalation of infections caused by drug-resistant bacteria worldwide poses a formidable challenge to global health, necessitating innovative approaches to combat this issue. The Vivli AMR Register consolidates antimicrobial susceptibility data from pharmaceutical industry surveillance programs, advancing the fight against antimicrobial resistance through the power of open data and collaboration.
Learn more about the Vivli AMR Register and how you can get involved in the 2024 Data Challenge